2
Total investments
1
Early stage
0
Mid stage
0
Late stage
10y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member & Investor
Sep 2023
Generated Health offers automated text messaging proven to change patient behavior and improve health outcomes while saving clinical time.
Florence has demonstrated ability to reach and engage all populations - with over 200,000 patient users across the UK, Australia, and now in the US.
We can help you deliver better care, more cost-effectively with powerful algorithms, and implement in less than two weeks.
Leverage the power of patient engagement to achieve the Quadruple Aim.
Board Member, RxDataScience Inc.
Nov 2016
RxDataScience Inc, a Syneos Health company, provides end-to-end advanced data analytics software solutions and services for biotech, pharmaceutical & healthcare companies. Our team brings deep domain expertise, along with a cutting-edge AI & ML technology applications to enable and accelerate data driven decisions along the entire biopharma and life science industry value chain.
We create agile data platforms and other custom-built solutions that offer game-changing insights from which business leaders can make intelligent business decisions fast.
We use a combination of robust data, data science, domain expertise, vector-native time series and memory-based technology, and AI and machine learning to locate and analyze key data, disseminate and track behaviors and trends, and predict outcomes across institutional and external landscapes quickly and accurately.
We offer a host of products and services from plug-and-play data lakes to in-depth intelligence reports and custom-designed software using AI and other analytics technology to harness the most crucial data to solve our customers’ business problems.
We believe through advanced data science, we can solve business problems
for life science companies and improve patient lives.
Experience · 3 entries
All (3)
Investments (2)
Founder (1)
Board (2)
2026
2023
Board Member & Investor
Sep 2023
Generated Health offers automated text messaging proven to change patient behavior and improve health outcomes while saving clinical time.
Florence has demonstrated ability to reach and engage all populations - with over 200,000 patient users across the UK, Australia, and now in the US.
We can help you deliver better care, more cost-effectively with powerful algorithms, and implement in less than two weeks.
Leverage the power of patient engagement to achieve the Quadruple Aim.
2016
Board Member, RxDataScience Inc.
Nov 2016
RxDataScience Inc, a Syneos Health company, provides end-to-end advanced data analytics software solutions and services for biotech, pharmaceutical & healthcare companies. Our team brings deep domain expertise, along with a cutting-edge AI & ML technology applications to enable and accelerate data driven decisions along the entire biopharma and life science industry value chain.
We create agile data platforms and other custom-built solutions that offer game-changing insights from which business leaders can make intelligent business decisions fast.
We use a combination of robust data, data science, domain expertise, vector-native time series and memory-based technology, and AI and machine learning to locate and analyze key data, disseminate and track behaviors and trends, and predict outcomes across institutional and external landscapes quickly and accurately.
We offer a host of products and services from plug-and-play data lakes to in-depth intelligence reports and custom-designed software using AI and other analytics technology to harness the most crucial data to solve our customers’ business problems.
We believe through advanced data science, we can solve business problems
for life science companies and improve patient lives.
Similar investors
Health Care early-stage investors in United States
Investor lists
Lists that match Larry A.'s portfolio
- Angel investors in the US6,019 investors
- Health Care early-stage investors in United States5,007 investors
- Analytics early-stage investors in United States4,115 investors
- Early-stage startup investors in United States3,677 investors






